These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25386813)

  • 41. [Radioimmunotherapy of follicular lymphoma: a step towards cure?].
    Ketterer N; Bischof Delaloye A; Helg C; Luthi F; Buchegger F
    Bull Cancer; 2007 Sep; 94(9):799-806. PubMed ID: 17878100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular lymphoma: management options in the era of targeted therapy.
    Peterson CG; Kahl BS
    Curr Treat Options Oncol; 2005 Jul; 6(4):297-308. PubMed ID: 15967083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refining the treatment of follicular lymphoma.
    Buske C; Gisselbrecht C; Gribben J; Letai T; McLaughlin P; Wilson W
    Leuk Lymphoma; 2008; 49 Suppl 1():18-26. PubMed ID: 18821429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current management of follicular lymphomas.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
    Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is watch and wait still acceptable for patients with low-grade follicular lymphoma?
    Armitage JO; Longo DL
    Blood; 2016 Jun; 127(23):2804-8. PubMed ID: 26994147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations for Clinical Trial Development in Follicular Lymphoma.
    Maddocks K; Barr PM; Cheson BD; Little RF; Baizer L; Kahl BS; Leonard JP; Fowler N; Gordon LI; Link BK; Friedberg JW; Ansell SM
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 28040699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment strategies in follicular lymphomas: current status and future perspectives.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
    J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
    Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
    Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follicular lymphoma: an update on biology and optimal therapy.
    Fischer L; Dreyling M
    Leuk Lymphoma; 2023 Apr; 64(4):761-775. PubMed ID: 37061956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Where to start? Upfront therapy for follicular lymphoma in 2018.
    Leonard JP; Nastoupil LJ; Flowers CR
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):185-188. PubMed ID: 30504308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controversies in follicular lymphoma: "who, what, when, where, and why?" (not necessarily in that order!).
    Czuczman MS
    Hematology Am Soc Hematol Educ Program; 2006; ():303-10. PubMed ID: 17124076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.
    Rodríguez-Abreu D; Llanos Muñoz M; Provencio Pulla M; Rueda Domínguez A; Isla Casado D;
    Clin Transl Oncol; 2010 Nov; 12(11):760-4. PubMed ID: 20974569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How to manage early-stage follicular lymphoma.
    Cencini E; Fabbri A; Mecacci B; Bocchia M
    Expert Rev Hematol; 2020 Oct; 13(10):1093-1105. PubMed ID: 32869685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989-2016.
    Dinnessen MAW; van der Poel MWM; Tonino SH; Visser O; Blijlevens NMA; de Jong D; Lam KH; Kersten MJ; Lugtenburg PJ; Dinmohamed AG
    Leukemia; 2021 Jun; 35(6):1683-1695. PubMed ID: 33046819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes.
    Nogueira DS; Lage LAPC; Culler HF; Pereira J
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):67-75. PubMed ID: 34580043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent landmark studies in follicular lymphoma.
    Sorigue M; Sancho JM
    Blood Rev; 2019 May; 35():68-80. PubMed ID: 30928169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How I manage patients with follicular lymphoma.
    Casulo C
    Br J Haematol; 2019 Aug; 186(4):513-523. PubMed ID: 31173345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initial Treatment of High Tumor Burden Follicular Lymphoma.
    Freeman CL; Sehn LH
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):673-687. PubMed ID: 32586573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical applicability of current prognostic models in follicular lymphoma: A systematic review.
    Jelicic J; Stauffer Larsen T; Bukumiric Z; Andjelic B
    Crit Rev Oncol Hematol; 2021 Aug; 164():103418. PubMed ID: 34246773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.